WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns

The World Health Organisation has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns.

Leave a Reply

Your email address will not be published. Required fields are marked *